1 Market Overview
    1.1 Adeno-Associated Virus Vectors in Gene Therapy Definition
    1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size and Forecast
        1.2.1 By Revenue, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        1.2.2 By Sales Volume, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        1.2.3 Global Adeno-Associated Virus Vectors in Gene Therapy Price Trend, 2020-2031
    1.3 China Adeno-Associated Virus Vectors in Gene Therapy Market Size and Forecast
        1.3.1 By Revenue, China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        1.3.2 By Sales Volume, China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        1.3.3 China Adeno-Associated Virus Vectors in Gene Therapy Price Trend, 2020-2031
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China Adeno-Associated Virus Vectors in Gene Therapy Share in Global Market, 2020-2031
        1.4.2 By Sales Volume, China Adeno-Associated Virus Vectors in Gene Therapy Share in Global Market, 2020-2031
        1.4.3 Adeno-Associated Virus Vectors in Gene Therapy Market Size: China VS Global, 2020-2031
    1.5 Adeno-Associated Virus Vectors in Gene Therapy Market Dynamics
        1.5.1 Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
        1.5.2 Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
        1.5.3 Adeno-Associated Virus Vectors in Gene Therapy Industry Trends
        1.5.4 Adeno-Associated Virus Vectors in Gene Therapy Industry Policy
2 Global Competitive Landscape by Company
    2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Company, 2020-2025
    2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Volume by Company, 2020-2025
    2.3 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Company, 2020-2025
    2.4 Global Adeno-Associated Virus Vectors in Gene Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Adeno-Associated Virus Vectors in Gene Therapy Concentration Ratio
    2.6 Global Adeno-Associated Virus Vectors in Gene Therapy Mergers & Acquisitions, Expansion Plans
    2.7 Global Adeno-Associated Virus Vectors in Gene Therapy Manufacturers Product Type
3 China Competitive Landscape by Company
    3.1 China Adeno-Associated Virus Vectors in Gene Therapy Revenue by Company, 2020-2025
    3.2 China Adeno-Associated Virus Vectors in Gene Therapy Sales Volume by Company, 2020-2025
    3.3 China Adeno-Associated Virus Vectors in Gene Therapy Adeno-Associated Virus Vectors in Gene Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.4 China Adeno-Associated Virus Vectors in Gene Therapy Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
    3.5 Chinese Local Players, Adeno-Associated Virus Vectors in Gene Therapy Domestic VS Export
    3.6 China Market, Adeno-Associated Virus Vectors in Gene Therapy Import & Export
        3.6.1 China Market, Adeno-Associated Virus Vectors in Gene Therapy Import & Export, 2020-2031
        3.6.2 China Adeno-Associated Virus Vectors in Gene Therapy Import & Export Trends
        3.6.3 Main Sources of China Adeno-Associated Virus Vectors in Gene Therapy Import
        3.6.4 Export Destination of China Adeno-Associated Virus Vectors in Gene Therapy
4 Adeno-Associated Virus Vectors in Gene Therapy Production by Region
    4.1 Global Adeno-Associated Virus Vectors in Gene Therapy Capacity, Production and Capacity Utilization, 2020-2031
    4.2 Global Geographic Distribution of Adeno-Associated Virus Vectors in Gene Therapy Manufacturers
    4.3 Global Major Manufacturers, Adeno-Associated Virus Vectors in Gene Therapy Capacity Expansion and Future Plans
    4.4 Global Adeno-Associated Virus Vectors in Gene Therapy Capacity by Region
    4.5 Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region
        4.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Production & Forecast by Region, 2020 VS 2024 VS 2031
        4.5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region, 2020-2025
        4.5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
    5.1 Adeno-Associated Virus Vectors in Gene Therapy Industry Chain
    5.2 Adeno-Associated Virus Vectors in Gene Therapy Upstream Analysis
        5.2.1 Adeno-Associated Virus Vectors in Gene Therapy Core Raw Materials
        5.2.2 Main Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Adeno-Associated Virus Vectors in Gene Therapy Production Mode
    5.6 Adeno-Associated Virus Vectors in Gene Therapy Procurement Model
    5.7 Adeno-Associated Virus Vectors in Gene Therapy Industry Sales Model and Sales Channels
        5.7.1 Adeno-Associated Virus Vectors in Gene Therapy Sales Model
        5.7.2 Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
6 Sights by Product Type
    6.1 Adeno-Associated Virus Vectors in Gene Therapy Classification
        6.1.1 Serotype 2 (AVV 2)
        6.1.2 Synthetic Serotypes
        6.1.3 Others
    6.2 by Type, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Type, Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2020-2031
    6.4 by Type, Global Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, 2020-2031
    6.5 by Type, Global Adeno-Associated Virus Vectors in Gene Therapy Price, 2020-2031
7 Sights by Application
    7.1 Adeno-Associated Virus Vectors in Gene Therapy Segment by Application
        7.1.1 Alzheimer's Disease
        7.1.2 Cystic Dibrosis
        7.1.3 Hemophilia B
        7.1.4 Parkinson's Disease
    7.2 by Application, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    7.3 by Application, Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2020-2031
    7.4 by Application, Global Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, 2020-2031
    7.5 by Application, Global Adeno-Associated Virus Vectors in Gene Therapy Price, 2020-2031
8 Sales Sights by Region
    8.1 By Region, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020 VS 2024 VS 2031
    8.2 By Region, Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2020-2031
    8.3 By Region, Global Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, 2020-2031
    8.4 North America
        8.4.1 North America Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecasts, 2020-2031
        8.4.2 By Country, North America Adeno-Associated Virus Vectors in Gene Therapy Market Size Market Share
    8.5 Europe
        8.5.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecasts, 2020-2031
        8.5.2 By Country, Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecasts, 2020-2031
        8.6.2 By Country/Region, Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Market Size Market Share
    8.7 South America
        8.7.1 South AmericaAdeno-Associated Virus Vectors in Gene Therapy Market Size & Forecasts, 2020-2031
        8.7.2 By Country, South America Adeno-Associated Virus Vectors in Gene Therapy Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & CAGR，2020 VS 2024 VS 2031
    9.2 By Country, Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2020-2031
    9.3 By Country, Global Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, 2020-2031
    9.4 United States
        9.4.1 United States Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.4.2 By Company, United States Adeno-Associated Virus Vectors in Gene Therapy Sales Volume Market Share, 2024
        9.4.3 by Type, United States Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.4.4 by Application, United States Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.5 Europe
        9.5.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.5.2 By Company, Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Volume Market Share, 2024
        9.5.3 by Type, Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.5.4 by Application, Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.6 China
        9.6.1 China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.6.2 By Company, China Adeno-Associated Virus Vectors in Gene Therapy Sales Volume Market Share, 2024
        9.6.3 by Type, China Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.6.4 by Application, China Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.7 Japan
        9.7.1 Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.7.2 By Company, Japan Adeno-Associated Virus Vectors in Gene Therapy Market Share, 2024
        9.7.3 by Type, Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.7.4 by Application, Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.8 South Korea
        9.8.1 South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.8.2 By Company, South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Share, 2024
        9.8.3 by Type, South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.8.4 by Application, South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.9 Southeast Asia
        9.9.1 Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.9.2 By Company, Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Share, 2024
        9.9.3 by Type, Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.9.4 by Application, Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.10 India
        9.10.1 India Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.10.2 By Company, India Adeno-Associated Virus Vectors in Gene Therapy Market Share, 2024
        9.10.3 by Type, India Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.10.4 by Application, India Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2020-2031
        9.11.2 By Company, Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Share, 2024
        9.11.3 by Type, Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
        9.11.4 by Application, Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size, Share, 2024 VS 2031
10 Manufacturers Profile
    10.1 Amicus Therapeutics
        10.1.1 Amicus Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.1.4 Amicus Therapeutics Company Profile and Main Business
        10.1.5 Amicus Therapeutics Recent Developments
    10.2 Asklepios Biopharmaceutical
        10.2.1 Asklepios Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.2.4 Asklepios Biopharmaceutical Company Profile and Main Business
        10.2.5 Asklepios Biopharmaceutical Recent Developments
    10.3 BioMarin Pharmaceutical
        10.3.1 BioMarin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        10.3.2 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.3.4 BioMarin Pharmaceutical Company Profile and Main Business
        10.3.5 BioMarin Pharmaceutical Recent Developments
    10.4 Coave Therapeutics
        10.4.1 Coave Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.4.4 Coave Therapeutics Company Profile and Main Business
        10.4.5 Coave Therapeutics Recent Developments
    10.5 MeiraGTx
        10.5.1 MeiraGTx Company Information, Head Office, Market Area, and Industry Position
        10.5.2 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.5.4 MeiraGTx Company Profile and Main Business
        10.5.5 MeiraGTx Recent Developments
    10.6 Neurocrine Biosciences
        10.6.1 Neurocrine Biosciences Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.6.4 Neurocrine Biosciences Company Profile and Main Business
        10.6.5 Neurocrine Biosciences Recent Developments
    10.7 Pfizer
        10.7.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
        10.7.2 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.7.4 Pfizer Company Profile and Main Business
        10.7.5 Pfizer Recent Developments
    10.8 Roche Holding
        10.8.1 Roche Holding Company Information, Head Office, Market Area, and Industry Position
        10.8.2 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.8.4 Roche Holding Company Profile and Main Business
        10.8.5 Roche Holding Recent Developments
    10.9 Sangamo Therapeutics
        10.9.1 Sangamo Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.9.2 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.9.4 Sangamo Therapeutics Company Profile and Main Business
        10.9.5 Sangamo Therapeutics Recent Developments
    10.10 Sarepta Therapeutics
        10.10.1 Sarepta Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.10.2 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.10.4 Sarepta Therapeutics Company Profile and Main Business
        10.10.5 Sarepta Therapeutics Recent Developments
    10.11 Spark Therapeutics
        10.11.1 Spark Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.11.2 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.11.4 Spark Therapeutics Company Profile and Main Business
        10.11.5 Spark Therapeutics Recent Developments
    10.12 Voyager Therapeutics
        10.12.1 Voyager Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.12.2 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.12.4 Voyager Therapeutics Company Profile and Main Business
        10.12.5 Voyager Therapeutics Recent Developments
    10.13 NightstaRx
        10.13.1 NightstaRx Company Information, Head Office, Market Area, and Industry Position
        10.13.2 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Models, Specifications, and Application
        10.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        10.13.4 NightstaRx Company Profile and Main Business
        10.13.5 NightstaRx Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer